Programming Pacemakers to Reduce and Terminate Atrial Fibrillation.


Journal

Current cardiology reports
ISSN: 1534-3170
Titre abrégé: Curr Cardiol Rep
Pays: United States
ID NLM: 100888969

Informations de publication

Date de publication:
13 09 2019
Historique:
entrez: 15 9 2019
pubmed: 15 9 2019
medline: 17 4 2020
Statut: epublish

Résumé

The goal of this paper is to review present knowledge regarding preventive and antitachycardia pacing algorithms, aimed to reduce atrial fibrillation (AF) burden in patients when pacing is indicated. Reactive antitachycardia pacing (ATP), the new generation of ATP, is significantly associated with a reduced risk of AF. In patients with indication for pacing and history of AF, pacemakers endowed with atrial preventive pacing and atrial ATP combined with managed ventricular pacing proved superior to standard dual-chamber pacing. Managed ventricular pacing is an algorithm that minimizes unnecessary right ventricular pacing. Progression to persistent AF is prevented by ventricular pacing minimization in patients with normal PR interval. The synergistic effect of pacemakers that combine atrial preventive pacing with reactive ATP and with algorithms that minimize ventricular pacing can reduce AF incidence and decrease the combined endpoint of permanent AF, hospital admissions, and mortality.

Identifiants

pubmed: 31520271
doi: 10.1007/s11886-019-1214-9
pii: 10.1007/s11886-019-1214-9
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

127

Références

N Engl J Med. 2000 May 11;342(19):1385-91
pubmed: 10805823
J Am Coll Cardiol. 2001 Jul;38(1):167-72
pubmed: 11451268
J Cardiovasc Electrophysiol. 2001 Oct;12(10):1121-8
pubmed: 11699520
Eur Heart J. 2002 Mar;23(6):477-82
pubmed: 11863350
N Engl J Med. 2002 Jun 13;346(24):1854-62
pubmed: 12063369
J Cardiovasc Electrophysiol. 2002 Jun;13(6):542-7
pubmed: 12108493
Circulation. 2003 Jun 17;107(23):2932-7
pubmed: 12782566
J Am Coll Cardiol. 2003 Jun 4;41(11):1926-32
pubmed: 12798559
Pacing Clin Electrophysiol. 2003 Jun;26(6):1336-41
pubmed: 12822749
J Am Coll Cardiol. 2003 Aug 20;42(4):627-33
pubmed: 12932592
J Cardiovasc Electrophysiol. 2003 Nov;14(11):1189-95
pubmed: 14678133
J Am Coll Cardiol. 2004 Jan 7;43(1):47-52
pubmed: 14715182
Europace. 2004 Jul;6(4):351-62
pubmed: 15172660
Circulation. 2005 Jan 18;111(2):240-3
pubmed: 15657388
J Cardiovasc Electrophysiol. 2005 Jul;16(7):714-23
pubmed: 16050828
Europace. 2006 Mar;8(3):204-10
pubmed: 16627441
Circulation. 2006 Jul 4;114(1):11-7
pubmed: 16801463
N Engl J Med. 2007 Sep 6;357(10):1000-8
pubmed: 17804844
Europace. 2007 Dec;9(12):1110-8
pubmed: 18042619
Europace. 2008 Jan;10(1):28-34
pubmed: 18199572
Eur Heart J. 2010 Apr;31(8):976-83
pubmed: 20071325
Eur Heart J. 2011 Mar;32(6):686-96
pubmed: 21300730
J Am Coll Cardiol. 2011 Mar 15;57(11):e101-98
pubmed: 21392637
N Engl J Med. 2012 Jan 12;366(2):120-9
pubmed: 22236222
J Am Coll Cardiol. 2012 Aug 14;60(7):682-703
pubmed: 22854177
J Am Coll Cardiol. 2012 Oct 2;60(14):1297-313
pubmed: 22975230
Europace. 2013 Aug;15(8):1070-118
pubmed: 23801827
Am J Cardiol. 2013 Oct 15;112(8):1142-7
pubmed: 23831166
Eur Heart J. 2013 Sep;34(35):2746-51
pubmed: 23900699
Circulation. 2014 Feb 25;129(8):837-47
pubmed: 24345399
Eur Heart J. 2014 Sep 14;35(35):2352-62
pubmed: 24771721
Heart Rhythm. 2015 Aug;12(8):1717-25
pubmed: 25869753
Heart Rhythm. 2015 Nov;12(11):2239-46
pubmed: 26142300
Cardiol Clin. 2016 May;34(2):255-68
pubmed: 27150174
Europace. 2016 Nov;18(11):1609-1678
pubmed: 27567465
Curr Opin Cardiol. 2017 Jan;32(1):22-26
pubmed: 27875476
Europace. 2017 Dec 1;19(12):1981-1987
pubmed: 28039212
Heart Rhythm. 2017 Oct;14(10):1476-1484
pubmed: 28506917
Arch Mal Coeur Vaiss. 1978 Jun;71(6):645-56
pubmed: 28709
Heart Rhythm. 2017 Dec;14(12):1820-1825
pubmed: 28893549
J Am Coll Cardiol. 2019 Aug 20;74(7):932-987
pubmed: 30412710
Europace. 2019 Apr 1;21(4):539-547
pubmed: 30428056
Europace. 2019 Apr 1;21(4):636-644
pubmed: 30649270
Heart Rhythm. 2019 Aug;16(8):1204-1214
pubmed: 30772532
Pacing Clin Electrophysiol. 2019 Jul;42(7):970-979
pubmed: 30977146
Heart Rhythm. 2019 Jul;16(7):983-989
pubmed: 31102750
N Engl J Med. 1998 Apr 16;338(16):1097-104
pubmed: 9545357
Lancet. 1997 Oct 25;350(9086):1210-6
pubmed: 9652562
Circulation. 1998 Sep 8;98(10):946-52
pubmed: 9737513

Auteurs

Margarida Pujol-López (M)

Institut Clínic Cardiovascular (ICCV), Hospital Clínic, Universitat de Barcelona, Barcelona, Catalonia, Spain.

Rodolfo San Antonio (R)

Institut Clínic Cardiovascular (ICCV), Hospital Clínic, Universitat de Barcelona, Barcelona, Catalonia, Spain.

José María Tolosana (JM)

Institut Clínic Cardiovascular (ICCV), Hospital Clínic, Universitat de Barcelona, Barcelona, Catalonia, Spain.
Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.

Lluís Mont (L)

Institut Clínic Cardiovascular (ICCV), Hospital Clínic, Universitat de Barcelona, Barcelona, Catalonia, Spain. lmont@clinic.cat.
Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain. lmont@clinic.cat.
Institut Clínic Cardiovascular (ICCV), Hospital Clínic, Universitat de Barcelona, Catalonia, Spain. C/ Villarroel 170, 08036, Barcelona, Spain. lmont@clinic.cat.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH